A. Definition
- Respiratory arrest with asthma
- Fails to clear with usual treatment
- Requires intubation and mechanical ventillation
- Underlying bronchitis and/or pneumonia may be present
- Picornavirus or adenovirus infection may trigger severe asthma attacks [2]
B. Risk Factors for Life-Threatening Asthma (Table 3, Ref [3])
- Long duration and/or poor control of asthma
- Dependence on systemic glucocorticoids
- Noncompliance with medications
- Psychosocial factors
- Poor socioeconomic conditions
- Inconsistent medical followup
- Delayed medical care
- Older age
- Cigarette smoking
- Aspirin sensitivity
- Prior hospitalization for asthma
- Prior use of mechanical ventilation
C. Initial Treatment
- Components of severe asthma therapy
- Oxygen
- ß2-adrenergic agonist therapy - nebulized, subcutaneous (SC) or intravenous (IV)
- Epinephrine (non-specific adrenergic activity) - SC or IV
- Methylprednisolone - 125mg IV bolus then 60-80mg IV q6-8° (children 1-1.5mg/kg IV)
- Antibiotics - potential benefits may outweigh risks (consider cefuroxime 750mg IV q8°)
- Intubation
- Aminophylline
- ß2-Agonist Therapy
- ß2-agonist nebulization every 15-20 minutes
- Albuterol, metoproteranol, salbutamol are typically used
- Nebulized albuterol 5.0mg q40 minutes is preferred to 2.5mg q20 minutes [4]
- Severe asthma impedes entrance of nebulized drug to small airways
- Intravenous salbutamol in children reduced hospital stay and oxygen requirements [5]
- Epinephrine - usually for patients <40yrs, no history CAD. Initial dose 0.3cc 1:1000 sc.
- Consider adjunctive ipatropium bromide (Atrovent®) nebulizer (0.5mg in 3cc saline)
- Intubation and Mechanical Ventilation
- Usual indication: failed response to usual therapies (see below)
- Usually requires paralysis or at least sedation; set FiO2 100%
- If it requires paralysis, set low tidal volumes and low respiratory rates
- This allows for exhalation of delivered breaths, reduced barotrauma (high pressures)
- Aminophylline
- Generally recommended for severe asthma, especially when epinephrine cannot be used
- Load with 4-6mg/kg iv then drip 0.4-0.6mg/kg/hr
- Levels should be maintained 8-12µg/ml range, never >15µg/ml of serum
- There is no added benefit at >15µg/ml range and side effects are severe
- Other Bronchodilators
- Epinephrine - 0.3mL SC q20 minutes x 3 doses maximum; patients <30-35 years of age
- Terbutaline - may be used in pediatric cases, given SC or IV
- Isoproterenol - in very difficult cases with resistant disease, IV at 0.1mg/minute
D. Mechanical Ventilation
- Indications
- Respiratory rate increasing to >40 breaths per minute
- Peak flows decreasing with patient fatigue
- Rising PaCO2 and/or falling pH despite therapies
- Paralysis and sedation are often required
- Atracurium (curare derivative) may be used
- Vecuronium / Pavulon may lead to post-paralytic myopathy in up to 70% of patients
- Curare is relatively contraindicated due to increased histamine release
- Sedation with fentanyl, morphine, ± lorazepam or diazepam or midazolam
- Propofol may have bronchodilating effects and can be used for sedation
- AC or IMV Modes with initial tidal volumes 7-8cc/kg (as low as 5 cc/kg)
- High intrathoracic pressures and autopeep may lead to hypotension
- Support with generous IV fluids
- Up to 1 liter/hour
- Because of the poor venous return due to high intrathoracic pressures, patients require high intravascular volumes to maintain blood pressure
- Peak Inspiratory Pressure (PIP) typically ~90 cm
- Generally, these high PIPs are expected and not concerning
- PIPs should be used to follow improvement
- Plateau pressures should be normal
- Maintain plateau pressure <20cm
- Follow arterial blood gases (ABGs) for correction of acidosis
- Typically, initial ABG on 100% FiO2: pH 7.03, pO2 114, pCO2 92
- Acidosis should be corrected with bicarbonate to maintain pH > 7.25
- A HCO3- drip may be needed
- Weaning should only be attempted when PIPs
- Follow ventillator pressures
- Sedation may be lightened
- Diuretics may be used to improve compliance (especially if high volumes given initially)
- Acetazolamide (Diamox®; eg. 500mg iv qd) can decrease HCO3- and maintain pH
E. Heliox Therapy [1,6]
- Heliox is a blend of oxygen and helium with lower density and higher viscosity than air
- Inhalation of heliox converts turbulent flow in some bronchospastic airways to laminar
- Reduces the resistive work of breathing, unloads respiratory muscles
- Reverses hypercapnea in some patients with severe status asthmaticus
- Composed of 60-80% helium with oxygen mixed
- Use restricted to trained personell
References
- Manthous CA. 1995. Am J Med. 99(3):298
- Tan WC, Xiang X, Qiu D, et al. 2003. Am J Med. 115(4):272
- Wechsler ME, Shepard JO, Mark EJ. 2007. NEJM. 356(20):2083 (Case Record)
- McFadden ER Jr, Strauss L, Hejal R, et al. 1998. Am J Med. 105(1):12
- Browne GJ, Penna AS, Phung X, Soo M. 1997. Lancet. 349:301
- Kass JE and Castriotta RJ. 1995. Chest. 107:757